ATE173164T1 - Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen - Google Patents

Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen

Info

Publication number
ATE173164T1
ATE173164T1 AT95943245T AT95943245T ATE173164T1 AT E173164 T1 ATE173164 T1 AT E173164T1 AT 95943245 T AT95943245 T AT 95943245T AT 95943245 T AT95943245 T AT 95943245T AT E173164 T1 ATE173164 T1 AT E173164T1
Authority
AT
Austria
Prior art keywords
amount
pct
therapeutic dose
effective therapeutic
active ingredients
Prior art date
Application number
AT95943245T
Other languages
English (en)
Inventor
Bruno Bevan
Cecile Aillaud
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Application granted granted Critical
Publication of ATE173164T1 publication Critical patent/ATE173164T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT95943245T 1994-12-21 1995-12-19 Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen ATE173164T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9415416A FR2728463A1 (fr) 1994-12-21 1994-12-21 Systeme transdermique d'administration simultanee de plusieurs principes actifs

Publications (1)

Publication Number Publication Date
ATE173164T1 true ATE173164T1 (de) 1998-11-15

Family

ID=9470067

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95943245T ATE173164T1 (de) 1994-12-21 1995-12-19 Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen

Country Status (24)

Country Link
US (1) US5919477A (de)
EP (1) EP0800386B1 (de)
JP (1) JPH10510823A (de)
KR (1) KR980700071A (de)
CN (1) CN1072929C (de)
AT (1) ATE173164T1 (de)
AU (1) AU692042B2 (de)
CA (1) CA2208374A1 (de)
CZ (1) CZ183297A3 (de)
DE (1) DE69506007T2 (de)
DK (1) DK0800386T3 (de)
ES (1) ES2125679T3 (de)
FI (1) FI972542A (de)
FR (1) FR2728463A1 (de)
HK (1) HK1004375A1 (de)
HU (1) HUT77384A (de)
NO (1) NO972467L (de)
NZ (1) NZ298826A (de)
PL (1) PL182452B1 (de)
RU (1) RU2157193C2 (de)
SI (1) SI0800386T1 (de)
SK (1) SK280631B6 (de)
UA (1) UA42806C2 (de)
WO (1) WO1996019203A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2179646T3 (es) 1998-04-27 2003-01-16 Surmodics Inc Revestimiento que libera un agente bioactivo.
US20020188037A1 (en) * 1999-04-15 2002-12-12 Chudzik Stephen J. Method and system for providing bioactive agent release coating
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US6682757B1 (en) 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
US7097850B2 (en) 2002-06-18 2006-08-29 Surmodics, Inc. Bioactive agent release coating and controlled humidity method
US7243788B2 (en) * 2003-10-22 2007-07-17 Kimberly-Clark Worldwide, Inc. Package for segregating and mixing substances
ES2626784T3 (es) * 2003-10-28 2017-07-26 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos
US7541048B2 (en) 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
US8685421B2 (en) 2006-07-07 2014-04-01 Surmodics, Inc. Beaded wound spacer device
US20090202609A1 (en) * 2008-01-06 2009-08-13 Keough Steven J Medical device with coating composition
LT2782584T (lt) 2011-11-23 2021-09-10 Therapeuticsmd, Inc. Natūralios kombinuotos pakaitinės hormonų terapijos kompozicijos ir gydymas
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
JP6298468B2 (ja) 2012-10-16 2018-03-20 サーモディクス，インコーポレイテッド 創傷充填デバイスおよび方法
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US5023084A (en) * 1986-12-29 1991-06-11 Rutgers, The State University Of New Jersey Transdermal estrogen/progestin dosage unit, system and process
US4911707A (en) * 1987-02-13 1990-03-27 Ciba-Geigy Corporation Monolithic user-activated transdermal therapeutic system
US5071656A (en) * 1987-03-05 1991-12-10 Alza Corporation Delayed onset transdermal delivery device
US5538736A (en) * 1987-04-28 1996-07-23 Lts Lohmann Therapie-Systeme Gmbh Active substance-containing plaster for the controlled administration of active substances to the skin
DE3714140A1 (de) * 1987-04-28 1988-11-10 Lohmann Therapie Syst Lts Wirkstoffhaltiges pflaster zur kontrollierten verabreichung von wirkstoffen an die haut, seine verwendung sowie verfahren zur gesteuerten verabreichung von wirkstoffen an die haut
DE3903794A1 (de) * 1989-02-09 1990-08-16 Lohmann Therapie Syst Lts Therapeutisches system zur transdermalen oder transmucosalen verabreichung von wirkstoffen und seine verwendung
US5788983A (en) * 1989-04-03 1998-08-04 Rutgers, The State University Of New Jersey Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes
US5350581A (en) * 1989-12-14 1994-09-27 Pharmetrix Corporation Method for manufacturing transdermal devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator

Also Published As

Publication number Publication date
US5919477A (en) 1999-07-06
AU4450596A (en) 1996-07-10
EP0800386B1 (de) 1998-11-11
HUT77384A (hu) 1998-04-28
CN1072929C (zh) 2001-10-17
AU692042B2 (en) 1998-05-28
FR2728463B1 (de) 1997-02-21
FR2728463A1 (fr) 1996-06-28
HK1004375A1 (en) 1998-11-27
MX9704527A (es) 1997-10-31
SI0800386T1 (en) 1999-04-30
PL320883A1 (en) 1997-11-10
WO1996019203A1 (fr) 1996-06-27
CA2208374A1 (en) 1996-06-27
UA42806C2 (uk) 2001-11-15
RU2157193C2 (ru) 2000-10-10
SK280631B6 (sk) 2000-05-16
CN1170359A (zh) 1998-01-14
FI972542A0 (fi) 1997-06-16
NZ298826A (en) 1998-10-28
DE69506007D1 (de) 1998-12-17
PL182452B1 (pl) 2002-01-31
DE69506007T2 (de) 1999-06-10
DK0800386T3 (da) 1999-07-26
CZ183297A3 (en) 1997-10-15
KR980700071A (ko) 1998-03-30
JPH10510823A (ja) 1998-10-20
ES2125679T3 (es) 1999-03-01
NO972467D0 (no) 1997-05-30
EP0800386A1 (de) 1997-10-15
NO972467L (no) 1997-06-17
FI972542A (fi) 1997-06-16
SK79197A3 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
ATE173164T1 (de) Transdermales system zur gleichzeitigen verabreichung von mehreren wirkstoffen
BG103552A (en) Therapeutical forms
ATE190225T1 (de) Arzneiform zur abgabe von wirkstoffen an wunden
ATE321529T1 (de) Dosierungsform für eine verzögerte und zunehmende wirkstoffsfreisetzung
NO931766D0 (no) Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin
ATE146677T1 (de) Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ATE295157T1 (de) Mittel zur transdermalen verabreichung von arzneistoffen
ATE280575T1 (de) Transdermales therapeutisches system zur anwendung von candesartan
ATE240097T1 (de) Pharmaceutische zusammensetzung enthaltend (+)- ephedrin und einen h1 rezeptor antagonisten
TH16766A (th) ยาเตรียมที่ให้ผ่านทางผิวหนัง

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee